O	0	6	Update
O	7	9	in
O	10	17	Current
O	18	29	Diagnostics
O	30	33	and
O	34	46	Therapeutics
O	47	49	of
B-Disease	50	53	Dry
I-Disease	54	57	Eye
I-Disease	58	65	Disease
O	65	66	.

B-Disease	68	71	Dry
I-Disease	72	75	eye
I-Disease	76	83	disease
O	84	85	(
B-Disease	85	88	DED
O	88	89	)
O	90	100	represents
O	101	102	a
O	103	116	heterogeneous
O	117	122	group
O	123	125	of
O	126	136	conditions
O	137	141	with
B-Symptom	142	146	tear
I-Symptom	147	151	film
I-Symptom	152	165	insufficiency
O	166	169	and
O	170	175	signs
O	176	179	and
O	179	180	/
O	180	182	or
O	183	191	symptoms
O	192	194	of
B-Symptom	195	201	ocular
I-Symptom	202	209	surface
I-Symptom	210	220	irritation
O	220	221	.

O	222	225	The
O	226	234	clinical
O	235	249	manifestations
O	250	252	of
B-Disease	253	256	DED
O	257	260	can
O	261	263	be
O	264	270	highly
O	271	279	variable
O	279	280	;
O	281	286	hence
O	287	290	the
O	291	300	diagnosis
O	301	303	is
O	304	309	often
O	310	315	based
O	316	318	on
O	319	320	a
O	321	332	combination
O	333	335	of
O	336	344	symptoms
O	344	345	,
O	346	351	signs
O	351	352	,
O	353	356	and
O	357	365	clinical
O	366	371	tests
O	371	372	,
O	373	378	given
O	379	383	that
O	384	387	any
O	388	391	one
O	392	394	of
O	395	400	these
O	401	406	alone
O	407	412	would
O	413	417	miss
O	418	419	a
O	420	431	significant
O	432	438	number
O	439	441	of
O	442	450	patients
O	450	451	.

O	452	461	Similarly
O	461	462	,
O	463	466	the
O	467	476	treatment
O	477	481	must
O	482	487	often
O	488	490	be
O	491	499	tailored
O	500	502	to
O	503	507	each
O	508	515	patient
O	516	518	by
O	519	528	targeting
O	529	532	the
O	533	541	specific
O	542	552	mechanisms
O	553	561	involved
O	562	564	in
O	565	568	his
O	569	571	or
O	572	575	her
O	576	583	disease
O	583	584	.

O	585	588	The
O	589	596	purpose
O	597	599	of
O	600	604	this
O	605	611	review
O	612	614	is
O	615	617	to
O	618	627	summarize
O	628	634	recent
O	635	643	advances
O	644	648	that
O	649	653	have
O	654	661	allowed
O	662	664	us
O	665	667	to
O	668	674	better
O	675	684	recognize
O	684	685	,
O	686	696	categorize
O	696	697	,
O	698	701	and
O	702	707	treat
O	708	716	patients
O	717	721	with
B-Disease	722	725	DED
O	725	726	.

O	727	730	The
O	731	735	most
O	736	743	notable
O	744	747	new
O	748	758	diagnostic
O	759	764	tests
O	765	767	in
B-Disease	768	771	DED
O	772	775	are
B-Diagnostic_tool	776	780	tear
I-Diagnostic_tool	781	785	film
I-Diagnostic_tool	786	796	osmolarity
O	796	797	,
B-Diagnostic_tool	798	810	inflammatory
I-Diagnostic_tool	811	821	biomarkers
O	821	822	,
O	823	826	and
B-Diagnostic_tool	827	836	meibomian
I-Diagnostic_tool	837	842	gland
I-Diagnostic_tool	843	850	imaging
O	850	851	.

O	852	867	Therapeutically
O	867	868	,
O	869	873	anti
O	873	874	-
O	874	886	inflammatory
O	887	894	therapy
O	894	895	,
O	896	905	meibomian
O	906	911	gland
O	912	919	heating
O	920	923	and
O	924	934	expression
O	934	935	,
O	936	939	and
O	940	947	scleral
O	948	955	contact
O	956	962	lenses
O	963	966	are
O	967	971	some
O	972	974	of
O	975	978	the
O	979	985	latest
O	986	993	options
O	994	1003	available
O	1004	1007	for
O	1008	1016	treating
B-Disease	1017	1020	DED
O	1020	1021	.
